Clinical results of proton beam therapy for advanced neuroblastoma.

Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.

Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy.

Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.

Base of skull chordomas in children and adolescents. A clinicopathologic study of 73 cases.

Proton versus photon radiation therapy for patients with high-risk neuroblastoma: the need for a customized approach.

Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.

Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies.

Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors.

Proton Radiotherapy for Pediatric Bladder/ Prostate Rhabdomyosarcoma: clinical Outcomes and Dosimetry Compared to Intensity Modulated Radiation Therapy.

Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.

Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes.

Definitive treatment of leptomeningeal spinal metastases in children.

Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.

Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy.

Breast cancer screening for childhood cancer survivors after craniospinal irradiation with protons versus x-rays: a dosimetric analysis and review of the literature.

Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at Paul Scherrer Institute.

Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.

Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.

Proton radiotherapy for pediatric sarcoma.

The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.

Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade glioma.

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.

Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.

Practice patterns of photon and proton pediatric image guided radiation treatment: results from an International Pediatric Research consortium.

Proton radiation therapy for the treatment of retinoblastoma.

Proton radiotherapy for pediatric tumors: review of first clinical results.

Proton beam radiotherapy of progressive pediatric choroidal osteoma: first experience.

Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.

Practical aspects of pediatric proton radiation therapy.

Spot-scanning proton therapy for malignant soft tissue tumors in childhood: first experiences at the Paul Scherrer Institute.

Preparation of pediatric patients for treatment with proton beam therapy.

Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade glioma.

Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.

Treatment tolerance of particle therapy in pediatric patients.

Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.

Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy.

Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors.

Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.

Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Breast cancer after chest radiation therapy for childhood cancer.

Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.

Preli.minary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma

The u.se of proton therapy in the treatment of benign or low-grade pediatric brain tumors

Embryonal brain tumors.